Momence, IL - FutureCeuticals today announced the issuance of a patent in Japan covering the production of products from whole coffee fruit or portions thereof, including coffee fruit powders, extracts, and concentrates. The patent also covers use of coffee fruit products as ingredients in food and beverage and dietary supplement products.
The patent extends the company’s global stable of intellectual property covering the processing and safe use of the coffee fruit.
“Because the fruit of the coffee plant (coffee cherries) tends to rapidly spoil following harvest, it had historically been overlooked for food and beverage applications as unfit for human consumption,” said John Hunter, Executive Vice President of FutureCeuticals.
“Our team developed methods, now patented throughout the world, for preserving and processing the fruit prior to spoiling. These latest patents, together with our developing body of clinical research on the unique health benefits of the whole coffee fruit, further cement our standing as the only choice for safe, functional, potent, and protected coffee fruit products. Our coffee fruit IP creates a unique platform for the development of truly groundbreaking products and partnerships”, he added.
The company’s line of coffee fruit products is marketed worldwide under the Coffeeberry® brand name.
In one prominent example, Coffeeberry® brand coffee fruit from Kona, Hawaii, is the active ingredient in KonaRed, a line of juices made from the red ripe fruit of world famous Kona coffee.
About FutureCeuticals, Inc.
FutureCeuticals, Inc. is a vertically integrated functional food ingredient, product development, and bioanalytical research and discovery company with farms and facilities in Illinois, Indiana, Wisconsin, California, and Europe.
FutureCeuticals is a voting member of the Council for Responsible Nutrition, a voting member of the International Probiotics Association, and a sponsor of the American Botanical Council.
For more information on KonaRed or to inquire about distribution, please contact 808.212.1553 or send an email to email@example.com.